Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands |
Total |
At The Market Offerings [Member] |
Common Stock |
Common Stock
At The Market Offerings [Member]
|
Additional Paid-In Capital |
Additional Paid-In Capital
At The Market Offerings [Member]
|
Accumulated Other Comprehensive Income |
Retained Earnings |
| Beginning balance at Dec. 31, 2022 |
$ 1,235,584
|
|
$ 9
|
|
$ 2,420,223
|
|
$ (7,461)
|
$ (1,177,187)
|
| Beginning balance, shares at Dec. 31, 2022 |
|
|
87,103,007
|
|
|
|
|
|
| Issuance of common stock |
|
$ 1,466
|
|
|
|
$ 1,466
|
|
|
| Issuance of common stock, shares |
|
|
|
35,349
|
|
|
|
|
| Contingent consideration paid, shares |
|
|
567,045
|
|
|
|
|
|
| Contingent consideration paid |
24,126
|
|
|
|
24,126
|
|
|
|
| Exercise of stock options |
755
|
|
|
|
755
|
|
|
|
| Exercise of stock options, shares |
|
|
48,353
|
|
|
|
|
|
| Vesting of restricted stock units, shares |
|
|
342,025
|
|
|
|
|
|
| Stock-based compensation |
27,255
|
|
|
|
27,255
|
|
|
|
| Other comprehensive gain (loss) - unrealized gain (loss) on marketable securities |
2,989
|
|
|
|
|
|
2,989
|
|
| Other comprehensive gain (loss) - equity method investment |
1,794
|
|
|
|
|
|
1,794
|
|
| Net Income (Loss) |
(103,126)
|
|
|
|
|
|
|
(103,126)
|
| Ending balance at Mar. 31, 2023 |
1,190,843
|
|
$ 9
|
|
2,473,825
|
|
(2,678)
|
(1,280,313)
|
| Ending balance, shares at Mar. 31, 2023 |
|
|
88,095,779
|
|
|
|
|
|
| Beginning balance at Dec. 31, 2022 |
1,235,584
|
|
$ 9
|
|
2,420,223
|
|
(7,461)
|
(1,177,187)
|
| Beginning balance, shares at Dec. 31, 2022 |
|
|
87,103,007
|
|
|
|
|
|
| Other comprehensive gain (loss) - equity method investment |
2,086
|
|
|
|
|
|
|
|
| Net Income (Loss) |
(226,807)
|
|
|
|
|
|
|
|
| Ending balance at Jun. 30, 2023 |
1,104,888
|
|
$ 9
|
|
2,512,741
|
|
(3,868)
|
(1,403,994)
|
| Ending balance, shares at Jun. 30, 2023 |
|
|
88,347,634
|
|
|
|
|
|
| Beginning balance at Mar. 31, 2023 |
1,190,843
|
|
$ 9
|
|
2,473,825
|
|
(2,678)
|
(1,280,313)
|
| Beginning balance, shares at Mar. 31, 2023 |
|
|
88,095,779
|
|
|
|
|
|
| Exercise of stock options |
465
|
|
|
|
465
|
|
|
|
| Exercise of stock options, shares |
|
|
30,371
|
|
|
|
|
|
| Vesting of restricted stock units, shares |
|
|
151,853
|
|
|
|
|
|
| Issuance of shares under employee stock purchase plan |
2,051
|
|
|
|
2,051
|
|
|
|
| Issuance of shares under employee stock purchase plan, shares |
|
|
69,631
|
|
|
|
|
|
| Stock-based compensation |
36,400
|
|
|
|
36,400
|
|
|
|
| Other comprehensive gain (loss) - unrealized gain (loss) on marketable securities |
(1,482)
|
|
|
|
|
|
(1,482)
|
|
| Other comprehensive gain (loss) - equity method investment |
292
|
|
|
|
|
|
292
|
|
| Net Income (Loss) |
(123,681)
|
|
|
|
|
|
|
(123,681)
|
| Ending balance at Jun. 30, 2023 |
1,104,888
|
|
$ 9
|
|
2,512,741
|
|
(3,868)
|
(1,403,994)
|
| Ending balance, shares at Jun. 30, 2023 |
|
|
88,347,634
|
|
|
|
|
|
| Beginning balance at Dec. 31, 2023 |
$ 1,050,169
|
|
$ 9
|
|
2,710,797
|
|
(2,258)
|
(1,658,379)
|
| Beginning balance, shares at Dec. 31, 2023 |
92,997,158
|
|
92,997,158
|
|
|
|
|
|
| Issuance of common stock |
|
55,959
|
|
$ 1
|
|
55,958
|
|
|
| Issuance of common stock, shares |
|
|
|
2,209,938
|
|
|
|
|
| Exercise of stock options |
$ 1,958
|
|
|
|
1,958
|
|
|
|
| Exercise of stock options, shares |
|
|
110,734
|
|
|
|
|
|
| Vesting of restricted stock units, shares |
|
|
1,015,543
|
|
|
|
|
|
| Stock-based compensation |
34,176
|
|
|
|
34,176
|
|
|
|
| Other comprehensive gain (loss) - unrealized gain (loss) on marketable securities |
(821)
|
|
|
|
|
|
(821)
|
|
| Reclassification of other comprehensive loss - equity method investment |
2,132
|
|
|
|
|
|
2,132
|
|
| Net Income (Loss) |
(107,436)
|
|
|
|
|
|
|
(107,436)
|
| Ending balance at Mar. 31, 2024 |
1,036,137
|
|
$ 10
|
|
2,802,889
|
|
(947)
|
(1,765,815)
|
| Ending balance, shares at Mar. 31, 2024 |
|
|
96,333,373
|
|
|
|
|
|
| Beginning balance at Dec. 31, 2023 |
$ 1,050,169
|
|
$ 9
|
|
2,710,797
|
|
(2,258)
|
(1,658,379)
|
| Beginning balance, shares at Dec. 31, 2023 |
92,997,158
|
|
92,997,158
|
|
|
|
|
|
| Exercise of stock options, shares |
190,246
|
|
|
|
|
|
|
|
| Other comprehensive gain (loss) - equity method investment |
$ 0
|
|
|
|
|
|
|
|
| Net Income (Loss) |
(254,411)
|
|
|
|
|
|
|
|
| Ending balance at Jun. 30, 2024 |
$ 971,062
|
|
$ 10
|
|
2,884,997
|
|
(1,155)
|
(1,912,790)
|
| Ending balance, shares at Jun. 30, 2024 |
98,289,150
|
|
98,289,150
|
|
|
|
|
|
| Beginning balance at Mar. 31, 2024 |
$ 1,036,137
|
|
$ 10
|
|
2,802,889
|
|
(947)
|
(1,765,815)
|
| Beginning balance, shares at Mar. 31, 2024 |
|
|
96,333,373
|
|
|
|
|
|
| Issuance of common stock |
|
$ 38,399
|
|
|
|
$ 38,399
|
|
|
| Issuance of common stock, shares |
|
|
|
1,592,823
|
|
|
|
|
| Exercise of stock options |
1,179
|
|
|
|
1,179
|
|
|
|
| Exercise of stock options, shares |
|
|
79,512
|
|
|
|
|
|
| Vesting of restricted stock units, shares |
|
|
195,691
|
|
|
|
|
|
| Issuance of shares under employee stock purchase plan |
1,669
|
|
|
|
1,669
|
|
|
|
| Issuance of shares under employee stock purchase plan, shares |
|
|
87,751
|
|
|
|
|
|
| Stock-based compensation |
40,861
|
|
|
|
40,861
|
|
|
|
| Other comprehensive gain (loss) - unrealized gain (loss) on marketable securities |
(208)
|
|
|
|
|
|
(208)
|
|
| Other comprehensive gain (loss) - equity method investment |
0
|
|
|
|
|
|
|
|
| Net Income (Loss) |
(146,975)
|
|
|
|
|
|
|
(146,975)
|
| Ending balance at Jun. 30, 2024 |
$ 971,062
|
|
$ 10
|
|
$ 2,884,997
|
|
$ (1,155)
|
$ (1,912,790)
|
| Ending balance, shares at Jun. 30, 2024 |
98,289,150
|
|
98,289,150
|
|
|
|
|
|